Studies on Thermostable Liver-Specific Antigens

1972 ◽  
Vol 42 (6) ◽  
pp. 871-884 ◽  
Author(s):  
I.O. Auer ◽  
F. Milgrom
Keyword(s):  
Liver Specific Antigens ◽  
Specific Antigens

Tolerance to Liver-Specific Antigens

1991 ◽  
Vol 122 (1) ◽  
pp. 33-46 ◽  
Author(s):  
James Forman ◽  
Kim Wieties ◽  
Robert E. Hammer
Keyword(s):  
Liver Specific Antigens ◽  
Specific Antigens

Studies on liver specific antigens—partial purification, characterization, and immunization

1983 ◽  
Vol 18 (3) ◽  
pp. 232-240 ◽  
Author(s):  
Terukatsu Arima ◽  
Hiroyuki Shimomura ◽  
Hideo Nagashima
Keyword(s):  
Partial Purification ◽  
Liver Specific Antigens ◽  
Specific Antigens

scholarly journals Studies on “Liver-Specific” Antigens

1979 ◽  
Vol 77 (5) ◽  
pp. 1045-1052 ◽  
Author(s):  
Ursula J. Behrens ◽  
Fiorenzo Paronetto
Keyword(s):  
Liver Specific Antigens ◽  
Specific Antigens

The incidence of liver specific antigens in liver disease

Pathology ◽  
1981 ◽  
Vol 13 (3) ◽  
pp. 579-586 ◽  
Author(s):  
Gayle C. Dart ◽  
J. Kaldor
Keyword(s):  
Liver Disease ◽  
Liver Specific Antigens ◽  
Specific Antigens

scholarly journals Studies on “Liver-Specific” Antigens

1979 ◽  
Vol 77 (5) ◽  
pp. 1053-1061 ◽  
Author(s):  
Ursula J. Behrens ◽  
Salvatore Vernace ◽  
Fiorenzo Paronetto
Keyword(s):  
Liver Specific Antigens ◽  
Specific Antigens

Lectin Binding to Human Breast Tumor Cells

1976 ◽  
Vol 34 ◽  
pp. 34-35
Author(s):  
Robert E. Nordquist ◽  
J. Hill Anglin ◽  
Michael P. Lerner
Keyword(s):  
Carcinoma Cell ◽  
Ricinus Communis ◽  
Lectin Binding ◽  
Low Frequency ◽  
Breast Carcinoma Cell Line ◽  
Human Breast ◽  
Human Breast Tumor ◽  
Duct Carcinoma ◽  
Specific Antigens ◽  
Ricin Agglutinin

A human breast carcinoma cell line (BOT-2) was derived from an infiltrating duct carcinoma (1). These cells were shown to have antigens that selectively bound antibodies from breast cancer patient sera (2). Furthermore, these tumor specific antigens could be removed from the living cells by low frequency sonication and have been partially characterized (3). These proteins have been shown to be around 100,000 MW and contain approximately 6% hexose and hexosamines. However, only the hexosamines appear to be available for lectin binding. This study was designed to use Concanavalin A (Con A) and Ricinus Communis (Ricin) agglutinin for the topagraphical localization of D-mannopyranosyl or glucopyranosyl and D-galactopyranosyl or DN- acetyl glactopyranosyl configurations on BOT-2 cell surfaces.

Characterization of HLA-A*0201 restricted cytotoxic CD8+ T cells directed against ewing tumor specific antigens

2009 ◽  
Vol 221 (03) ◽  
Author(s):  
S Pirson ◽  
U Thiel ◽  
H Bernhard ◽  
GHS Richter ◽  
S Burdach
Keyword(s):  
T Cells ◽  
Cd8 T Cells ◽  
Specific Antigens ◽  
Ewing Tumor

Adoptive Cell Therapy for Gastrointestinal Cancers

2020 ◽  
Vol 04 (04) ◽  
pp. 345-350
Author(s):  
Ryan J. Slovak ◽  
Hyun S. Kim
Keyword(s):  
Cell Therapy ◽  
Clinical Research ◽  
Solid Tumors ◽  
Immune Cells ◽  
Ex Vivo ◽  
Adoptive Cell Therapy ◽  
Hematologic Malignancies ◽  
Gastrointestinal Cancers ◽  
Gastrointestinal Malignancies ◽  
Specific Antigens

AbstractThe reinfusion of autologous or allogeneic immune cells that have been educated and/or engineered ex vivo to respond to tumor-specific antigens is termed “adoptive cell therapy.” While adoptive cell therapy has made tremendous strides in the treatment of hematologic malignancies, its utilization for solid tumors has lagged somewhat behind. The purpose of this article is to concisely review the clinical research that has been done to investigate adoptive cell therapy as a treatment for gastrointestinal malignancies.

Sign in / Sign up

Export Citation Format

Share Document